Tristetraprolin knockout (TTPKO) mice exhibit a systemic inflammatory syndrome that is characterized by cachexia, polyarticular synovial arthritis, dermatitis, and myeloid hyperplasia (4). This evidence concerns the gene ZFP36 and skin disorder.